| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |